United States · 
Who invested in MBrace Therapeutics?
MBrace Therapeutics's investors include Venrock and TPG.
United States · Series B startup
Who invested in MBrace Therapeutics
Funding summaryUpdated 26 Oct 2026
$85Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $85MNov 2023
- Investors
- 2
The rounds
- Nov 2023
Founders and team
From MBrace Therapeutics's own website: 3 on the team.
- Jay StamatisChief Executive Officer
- Reena DesaiChief Legal Officer and Corporate Secretary
- Sara Todd SullivanSenior VP, Head of Clinical Operations
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about MBrace Therapeutics
How much has MBrace Therapeutics raised?
MBrace Therapeutics has raised $85M across 1 round since 2023.
When did MBrace Therapeutics last raise?
MBrace Therapeutics's most recent round was a Series B of $85M in Nov 2023.
What was MBrace Therapeutics's biggest round?
Its most recent round, $85M in Nov 2023, is also its largest on record.
Who backed MBrace Therapeutics first?
MBrace Therapeutics's first round on record, in Nov 2023, was backed by Venrock and TPG.
What stage is MBrace Therapeutics at?
MBrace Therapeutics's latest named round is a Series B, in Nov 2023.
Where is MBrace Therapeutics based?
MBrace Therapeutics is based in the United States.
Companies like MBrace Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.